Lacunar infarcts are the main correlate with cognitive dysfunction in CADASIL

Stroke

Volumn 38, Issue 3, 2007, Pages 923-928

  Liem, Michael K ^a   Van Der Grond, Jeroen ^a   Haan, Joost ^a,b   Van Den Boom, Rivka ^a   Ferrari, Michel D ^a   Knaap, Yvette M ^a   Breuning, Martijn H ^a   Van Buchem, Mark A ^a   Middelkoop, Huub A M ^a,c   Oberstein, Saskia A J Lesnik ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNLAND HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

CADASIL; Cognition; Lacunar infarction; MRI

Indexed keywords

NOTCH3 RECEPTOR; NOTCH RECEPTOR; NOTCH3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BLEEDING; BRAIN INFARCTION; CEREBRAL ARTERY DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; WHITE MATTER; CADASIL; COMPARATIVE STUDY; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; PSYCHOLOGICAL ASPECT;

ADULT; BRAIN INFARCTION; CADASIL; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; RECEPTORS, NOTCH;

EID: 33947513534     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000257968.24015.bf     Document Type: Article

References (32)

1. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssiere C, Cruaud C, Maciazek J, Weissenbach J, Bousser MG, Bach JF, Tournier-Lasserve E. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511-1515.
2. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol (Berl). 1995;89:500-512.
3. Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G, Ebke M, Klockgether T, Gasser T. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44:731-739.
4. van den Boom R, Lesnik Oberstein SA, Ferrari MD, Haan J, Van Buchem MA. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging findings at different ages-3rd-6th decades. Radiology. 2003;229:683-690.
5. Lesnik Oberstein SA, van den Boom R, Van Buchem MA, van Houwelingen HC, Bakker E, Vollebregt E, Ferrari MD, Breuning MH, Haan J. Cerebral microbleeds in CADASIL. Neurology. 2001;57:1066-1070.
6. Taillia H, Chabriat H, Kurtz A, Verin M, Levy C, Vahedi K, Tournier-Lasserve E, Bousser MG. Cognitive alterations in non-demented CADASIL patients. Cerebrovasc Dis. 1998;8:97-101.
7. de Groot JC, de Leeuw FE, Oudkerk M, van Gijn J, Hofman A, Jolles J, Breteler MM. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol. 2002;52:335-341.
8. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.
9. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, Hofman A, Breteler MMB. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain. 2005;128:2034-2041.
10. Werring DJ, Frazer DW, Coward LJ, Losseff NA, Watt H, Cipolotti L, Brown MM, Jager HR. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain. 2004;127:2265-2275.
11. Chabriat H, Pappata S, Poupon C, Clark CA, Vahedi K, Poupon F, Mangin JF, Pachot-Clouard M, Jobert A, Le Bihan D, Bousser MG. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke. 1999;30:2637-2643.
12. Holtmannspotter M, Peters N, Opherk C, Martin D, Herzog J, Bruckmann H, Samann P, Gschwendtner A, Dichgans M. Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study. Stroke. 2005;36:2559-2565.
13. O'Sullivan M, Singhal S, Charlton R, Markus HS. Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia. Neurology. 2004;62:702-707.
14. O'Sullivan M, Barrick TR, Morris RG, Clark CA, Markus HS. Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology. 2005;65:1584-1590.
15. Lesnik Oberstein SA, Ferrari MD, Bakker E, van Gestel J, Kneppers AL, Frants RR, Breuning MH, Haan J. Diagnostic Notch3 sequence analysis in CADASIL: three new mutations in Dutch patients. Dutch CADASIL Research Group. Neurology. 1999;52:1913-1915.
16. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary, 2nd ed. New York: Oxford University Press; 1998.
17. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986;149:698-709.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
19. Wechsler DA. Standardized memory scale for clinical use. J Psychol. 1945;19:87-95.
20. Reitan R. Validity of the Trail Making Test as an indication of organic brain damage. Percept Mot Skills. 1958;8:271-276.
21. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1992;121:15-23.
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM-IV; 4th ed. Washington, DC: American Psychiatric Association; 1994.
23. Admiraal-Behloul F, van den Heuvel DMJ, Olofsen H, van Osch MJP, van der Grond J, Van Buchem MA, Relber JHC. Fully automatic segmentation of white matter hyperintensities in MR images of the elderly. Neuroimage. 2005;28:607-617.
24. Bokura H, Kobayashi S, Yamaguchi S. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study. J Neurol. 1998;245:116-122.
25. Dichgans M, Filippi M, Bruning R, Iannucci G, Berchtenbreiter C, Minicucci L, Uttner I, Crispin A, Ludwig H, Gasser T, Yousry TAa. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology. 1999;52:1361-1367.
26. Yousry TA, Seelos K, Mayer M, Bruning R, Uttner I, Dichgans M, Mammi S, Straube A, Mai N, Filippi Ma. Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). AJNR Am J Neuroradiol. 1999;20:91-100.
27. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995;346:934-939.
28. Iannucci G, Dichgans M, Rovaris M, Bruning R, Gasser T, Giacomotti L, Yousry TA, Filippi M. Correlations between clinical findings and magnetization transfer imaging metrics of tissue damage in individuals with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke. 2001;32:643-648.
29. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H. Diffusion tensor imaging: Concepts and applications. J Magnetic Resonance Imaging. 2001;13:534-546.
30. Jackson C, Sudlow C. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke. 2005;36:891-901.
31. Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain. 2004;127:2533-2539.
32. Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain. 2004;127:2031-2038.